MD SB986 | 2024 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Engrossed on April 5 2024 - 50% progression
Action: 2024-04-06 - Referred Rules and Executive Nominations
Pending: House Rules and Executive Nominations Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on April 5 2024 - 50% progression
Action: 2024-04-06 - Referred Rules and Executive Nominations
Pending: House Rules and Executive Nominations Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Prohibiting a 340B manufacturer from taking certain direct or indirect actions to limit or restrict the acquisition or delivery of a 340B drug; making a violation of the Act an unfair, abusive, or deceptive trade practice within the meaning of the Consumer Protection Act; and requiring the Maryland Prescription Drug Affordability Board to conduct a study of the 340B Program and report its findings and recommendations to the Senate Finance Committee and the House Health and Government Operations Committee on or before July 1, 2026.
Title
State Board of Pharmacy - Prohibition on Discrimination Against 340B Drug Distribution
Sponsors
Roll Calls
2024-04-05 - Senate - Third Reading Passed (Y: 37 N: 7 NV: 0 Abs: 3) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-04-06 | House | Referred Rules and Executive Nominations |
2024-04-05 | Senate | Third Reading Passed (37-7) |
2024-04-05 | Senate | Second Reading Passed with Amendments |
2024-04-05 | Senate | Favorable with Amendments {193327/1 Adopted |
2024-04-05 | Senate | Favorable with Amendments Report by Finance |
2024-02-06 | Senate | Hearing 3/08 at 1:00 p.m. |
2024-02-02 | Senate | First Reading Finance |
Same As/Similar To
HB1056 (Crossfiled) 2024-05-16 - Approved by the Governor - Chapter 962
Subjects
Attorney General
Committees and Commissions
Consumer Protection
Discipline
Discrimination
Drugs
Federal Government
Health - Insurance
Health Occupations
Health, Department of
Industry and Technology
Investigations and Inquiries
License Commissioners, Boards of
Penalties and Sentences
Pharmacists and Pharmacies
Reports
studies
Unfair Trade Practices
Wholesale Distribution
Committees and Commissions
Consumer Protection
Discipline
Discrimination
Drugs
Federal Government
Health - Insurance
Health Occupations
Health, Department of
Industry and Technology
Investigations and Inquiries
License Commissioners, Boards of
Penalties and Sentences
Pharmacists and Pharmacies
Reports
studies
Unfair Trade Practices
Wholesale Distribution
Code Citations
Chapter | Article | Section | Citation Type | Statute Text |
---|---|---|---|---|
Commercial Law | 13 | 301 | (n/a) | See Bill Text |
Health Occupations | 12 | 101 | (n/a) | See Bill Text |
Health Occupations | 12 | 6C-09.1 | (n/a) | See Bill Text |